Status: Recruiting
Exspanding the Knowledge About TNPO2-Associated Disorders
The Target-TNPO2 is an international, multicenter observational registry designed to collect comprehensive clinical, genetic, neurodevelopmental, and longitudinal data from individuals with pathogenic or likely pathogenic variants in the TNPO2 gene. This aids to improve the knowledge and clinical progression on TNPO2-associated disorders. The investigators further aim to provide new insides into the pathomechanism of TNPO2 variants using blood samples.
Participants needed: 50
Trial details
Biological sex: AllType: ObservationalSponsor: Charite University, Berlin, GermanyUpdated: Jul 13, 2026Locations: 1Duration: 10 Years
Eligibility criteria
TNPO2 variant
no consent